Physician-led clinical research in the heart of Hialeah. Bringing investigators, research partners, and our diverse South Florida community together.
Integrated Health Research LLC · Hialeah, Florida
Design concept based on site photography; illustrates proposed improvements.
We are an outpatient clinical research site building lasting partnerships around scientific rigor, ethical responsibility, and compassionate care.
Advance medical knowledge through ethical, high-quality clinical research that prioritizes participant safety, dignity, and informed choice. We connect our diverse South Florida community with research opportunities and collaborate with investigators, sponsors, and CROs to generate reliable data for the development of new therapies.
Become a trusted clinical research center in South Florida, recognized for scientific integrity, compassionate attention, and meaningful representation of diverse communities. We aspire to build lasting partnerships that help bring medical innovation closer to patients and contribute to a healthier future.
Clear explanations, informed decisions, and respectful communication throughout the participant journey.
Protocol-focused planning, careful documentation, and physician oversight tailored to each study.
Our Hialeah location and physician practice referral relationships support outreach to South Florida’s diverse population. Eligibility is always assessed individually.
Explore the latest visual design prepared for our office, from the waiting area to clinical and research workspaces. Select an image to enlarge it.
Design concepts: digitally edited images, not verification of the current facilities.
A responsive South Florida partner for feasibility discussions, investigator collaboration, and participant-focused study planning.
Direct protocol discussion with physician leadership, supported by internal medicine and clinical research operations experience.
Outpatient space for participant visits, coordination, documentation, and temperature-controlled storage. Available equipment includes −80°C, −40°C, and +20°C units.
Community connections and referrals from collaborating physicians’ practices help identify potential participants for protocol-specific screening.
Study-specific resources, equipment configuration, investigator availability, and requirements are confirmed during feasibility. Study opportunities under review are not advertised as active enrollment.
Start a feasibility discussion ↗ Download site capabilities
Board-certified internal medicine physician with experience in hospital medicine, hospice and palliative care, clinical teaching, and patient safety. His background includes scholarly presentations at ACP Florida and CHEST.
Languages: English and Spanish
Physician with family medicine and clinical trial operations experience. Her professional background includes study management roles at AbbVie, ICON Clinical Research, and Precision for Medicine, spanning startup through closeout.
Languages: English, Spanish and FrenchAreas reflect the investigators’ documented clinical or research background, rather than a list of studies currently recruiting at this site. Prior employers are not presented as site sponsors or partners.
Clinical research helps evaluate potential treatments and improve medical knowledge. Participation begins with a conversation, never a commitment.
Ask about available opportunities and how screening works.
The team explains the study purpose, procedures, schedule, and known risks before you decide.
Participation is voluntary. You may ask questions and choose to withdraw.
Each study has its own eligibility criteria. Only protocol-specific screening can determine whether you qualify.
Please do not send medical records or sensitive health information through general email. Call our team to discuss an appropriate way to share information.
Sponsors, CROs, referring physicians, and prospective participants: our team welcomes your questions.
integratehealthresearch@gmail.com ↗We collect contact details only to respond to requests. Do not send medical information. Email links open your email application; use the interest form to submit a request.
3750 W 16th Avenue, Suite 236U
Hialeah, FL 33012
Monday–Friday: 11:00 AM–7:30 PM
Saturday: 9:00 AM–12:00 PM
Sunday: Closed
Please call to confirm your visit. Study visits follow the applicable protocol and appointment schedule.
Choose the right path. Our team reviews each request before arranging a follow-up.
Request a call about current or future study opportunities. This is not enrollment, eligibility screening, or consent to participate in a study. Do not enter diagnoses or medical records.
Share a general inquiry. Send confidential protocols and feasibility documents only through a channel agreed with our team.
These forms collect contact information and general business inquiries so Integrated Health Research can review and follow up. Submissions are stored on the website hosting service and accessible to the authorized site administrator. Please do not submit Social Security numbers, insurance details, medical information, or confidential protocols. To correct or remove your request, contact 305-927-5049 or integratehealthresearch@gmail.com and provide your reference number. No automatic email or text message is sent by these forms.
Website contact data is used to review and respond to requests. Access is limited to the authorized administrator. Closed requests are reviewed for removal after 180 days; information needed for a lawful obligation is handled separately. This period does not apply to clinical study records. Request access, correction, deletion, or withdrawal of contact permission by phone or email. Identity is verified before releasing information. This website’s contact permission is not HIPAA authorization or consent to a clinical study.
Understand the rules and oversight that may apply to medical research, and how to ask questions before sharing health information or joining a study.
HIPAA is a U.S. law, not a certifying organization. HHS’s Office for Civil Rights enforces its Privacy, Security, and Breach Notification Rules for covered entities and business associates. For research, protected health information generally requires an authorization or another permitted legal basis. Applicability depends on the entity and activity.
HIPAA and research ↗Institutional Review Boards review research protocols and consent materials to protect participants’ rights and welfare. The applicable IRB and its contact details are identified in the study documents. Ask the research team about the review and approval applicable to any proposed study.
How IRBs protect participants ↗For clinical investigations within FDA jurisdiction, federal rules address informed consent and IRB oversight, including 21 CFR Parts 50 and 56. Consent is a discussion of the study’s purpose, procedures, risks, possible benefits, and alternatives—not simply a signature.
FDA informed consent guidance ↗The Office for Human Research Protections supports protection of people in HHS-conducted or supported research. The Common Rule (45 CFR Part 46, Subpart A) establishes protections for research within its scope. Additional protections may apply to children and other specified populations. These rules do not automatically cover every privately funded study.
OHRP and the Common Rule ↗The interest forms request basic contact details and general business inquiries. They do not perform medical screening or collect study consent. Do not submit diagnoses, test results, insurance information, Social Security numbers, or medical records in the forms, chatbot, or general email.
For medical information, ask our team to arrange an appropriate channel and explain the applicable privacy documents. To correct or remove a website contact request, call 305-927-5049 and provide your reference number.
Read the form privacy noticeContact Integrated Health Research at 305-927-5049 to discuss a privacy concern or request the privacy documentation applicable to your care or study. Where HIPAA applies, you may also file a privacy or security complaint with HHS’s Office for Civil Rights.
HHS / OCR complaint information ↗When applicable, the HIPAA Security Rule requires administrative, physical, and technical safeguards for electronic protected health information. HIPAA privacy rights can include access to records, requests for amendments, and certain limits or confidential communications, subject to legal conditions and exceptions. Ask the responsible provider or study team how these rights apply.
HIPAA Security Rule ↗These official resources explain regulatory frameworks. Their inclusion does not represent government endorsement, a HIPAA certification, or approval of a specific Integrated Health Research study. Study-specific protections are explained in the applicable consent and privacy documents.
A curated selection from established medical journals. Explore clinical findings, research methods, and perspectives on the future of medical research.
Selection reviewed: October 10, 2026 · Publication years shown on each article.
Updated recommendations help authors explain how randomized trials were conducted and what they found. The guidance supports transparent reporting so readers can evaluate the evidence.
A reporting guideline does not establish the efficacy of a treatment.
CONSORT 2025 statement: updated guideline for reporting randomised trials
DOI: 10.1136/bmj-2024-081123
A 71-person, 12-week trial evaluated rentosertib, developed using generative AI, in idiopathic pulmonary fibrosis. Safety was the primary endpoint; lung-function findings supported further investigation.
Small, short-duration study; larger trials are needed to establish clinical benefit.
A generative AI-discovered TNIK inhibitor for idiopathic pulmonary fibrosis: a randomized phase 2a trial
DOI: 10.1038/s41591-025-03743-2
A prespecified pooled analysis of two trials compared semaglutide with placebo in obesity-related heart failure with preserved ejection fraction. The treatment improved symptoms and physical limitations and reduced body weight in the studied population.
Findings should not be generalized to every form of heart failure.
STEP-HFpEF and STEP-HFpEF DM: pooled analysis
DOI: 10.1016/S0140-6736(24)00469-0
This commentary addresses diversity across clinical-trial participation and leadership. It offers a perspective on representation in the research enterprise.
Commentary, rather than a randomized test of an intervention.
Why diversity is needed at every level of clinical trials, from participants to leaders
DOI: 10.1038/s41591-024-02914-x
In people with established cardiovascular disease and overweight or obesity but without diabetes, SELECT found fewer major cardiovascular events with semaglutide than placebo. The trial examined cardiovascular outcomes in a defined high-risk population.
Results apply to the trial population; individual treatment requires medical evaluation.
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes
DOI: 10.1056/NEJMoa2307563
Intensive blood-pressure control reduced mild cognitive impairment in this trial but did not significantly reduce probable dementia. The findings illustrate why primary and secondary outcomes must be interpreted separately.
Early trial termination and fewer dementia cases limited the dementia analysis.
Effect of Intensive vs Standard Blood Pressure Control on Probable Dementia: A Randomized Clinical Trial
DOI: 10.1001/jama.2018.21442
No articles match these filters. Try another topic or clear your search.
Educational summaries prepared for this website. These are external publications, not studies advertised as recruiting at Integrated Health Research. They do not replace medical advice or indicate endorsement by the journals. Publisher access terms may apply to the original articles.
Call 305-927-5049 before traveling to confirm the entrance, parking, elevator or step-free access, and whether a companion may attend. Our team will discuss your needs and study-specific arrangements.
We aim to make this website usable with a keyboard, assistive technology, and both color themes. If anything prevents access, call 305-927-5049 or email integratehealthresearch@gmail.com with the subject Website accessibility. We can help by phone. A formal accessibility certification has not been completed.
Response target: one business day, Monday–Friday. This website is not monitored for emergencies; call 911 for a medical emergency.